1. Association between baseline body mass index and survival in men with metastatic hormone‐sensitive prostate cancer: ECOG‐ACRIN CHAARTED E3805. Issue 12 (10th May 2022) Authors: Morgans, Alicia K.; Chen, Yu‐Hui; Jarrard, David F.; Carducci, Michael; Liu, Glenn; Eisenberger, Mario; Plimack, Elizabeth R.; Bryce, Alan; Garcia, Jorge A.; Dreicer, Robert; Vogelzang, Nicholas J.; Picus, Joel; Shevrin, Daniel; Hussain, Maha; DiPaola, Robert S.; Cella, David; Sweeney, Christophe... Journal: Prostate Issue: Volume 82:Issue 12(2022) Page Start: 1176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA. Issue 2 (11th August 2020) Authors: Barata, Pedro; Agarwal, Neeraj; Nussenzveig, Roberto; Gerendash, Benjamin; Jaeger, Ellen; Hatton, Whitley; Ledet, Elisa; Lewis, Brian; Layton, Jodi; Babiker, Hani; Bryce, Alan; Garje, Rohan; Stein, Cy; Kiedrowski, Lesli; Saylor, Philip; Sartor, Oliver Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CMET-05. EVALUATING RADIATION NECROSIS IN PATIENTS WITH INTRACRANIAL METASTASES FROM MELANOMA. (11th November 2019) Authors: Edmonds, Victoria; Thomson, Holly; Sharma, Akanksha; Butterfield, Richard; Zhang, Nan; Sio, Terence; Vora, Sujay; Daniels, Thomas; Schild, Steven; Ashman, Jonathan; Patel, Naresh; Zimmerman, Richard; Mrugala, Maciej; DeLeon, Thomas; Bryce, Alan; Porter, Alyx Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer. (2021) Authors: Taza, Fadi; Holler, Albert E.; Fu, Wei; Wang, Hao; Adra, Nabil; Albany, Costantine; Ashkar, Ryan; Cheng, Heather H.; Sokolova, Alexandra O.; Agarwal, Neeraj; Kessel, Adam; Bryce, Alan; Nafissi, Nellie; Barata, Pedro; Sartor, A. Oliver; Bastos, Diogo; Smaletz, Oren; Berchuck, Jacob E.; Taplin, Mar... Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial. Issue 4 (April 2015) Authors: Weber, Jeffrey S; D'Angelo, Sandra P; Minor, David; Hodi, F Stephen; Gutzmer, Ralf; Neyns, Bart; Hoeller, Christoph; Khushalani, Nikhil I; Miller, Wilson H; Lao, Christopher D; Linette, Gerald P; Thomas, Luc; Lorigan, Paul; Grossmann, Kenneth F; Hassel, Jessica C; Maio, Michele; Sznol, Mario; Asc... Journal: Lancet oncology Issue: Volume 16:Issue 4(2015:Apr.) Page Start: 375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial. Issue 4 (April 2015) Authors: Weber, Jeffrey S; D'Angelo, Sandra P; Minor, David; Hodi, F Stephen; Gutzmer, Ralf; Neyns, Bart; Hoeller, Christoph; Khushalani, Nikhil I; Miller, Wilson H; Lao, Christopher D; Linette, Gerald P; Thomas, Luc; Lorigan, Paul; Grossmann, Kenneth F; Hassel, Jessica C; Maio, Michele; Sznol, Mario; Asc... Journal: Lancet oncology Issue: Volume 16:Issue 4(2015:Apr.) Page Start: 375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗